OMOP vs FHIR: Which Standard for Health Research?

OMOP and FHIR solve different problems, and the honest answer to “which one?” is usually “both, in different places”. Health Level Seven’s Fast Healthcare Interoperability Resources (FHIR) is an exchange standard: it moves clinical data between systems in real time through modern web APIs. The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), maintained by the Observational Health Data Sciences and Informatics (OHDSI) community, is an analysis standard: it restructures data from any source into one consistent, deeply curated shape so that the same study code runs identically across hundreds of databases. Research infrastructures typically use FHIR to extract and transport data, and OMOP to analyse it.

Why this matters now

Two regulatory currents have pushed this comparison from an informatics debate to a procurement question. In the United States, certified electronic health record systems are required to expose standardised FHIR APIs, making FHIR the de facto doorway to clinical data. In Europe, the European Health Data Space (EHDS) regulation establishes a legal framework for the secondary use of health data at continental scale — and secondary use at scale is precisely the workload the OMOP CDM was designed for, as demonstrated by OHDSI network studies that have run identical analyses across dozens of countries. Programmes now being designed — national genomics initiatives, federated hospital networks, real-world evidence platforms — must decide where each standard sits in their architecture, because retrofitting either one later is expensive.

What each standard actually is

OMOP CDM: one shape for every database

The OMOP CDM (currently v5.4 in wide production use) defines a relational schema — person, condition occurrence, drug exposure, measurement, visit occurrence, and the rest — plus something at least as important: the OHDSI standardised vocabularies. Every source code, whether ICD-10, Read, or a local laboratory dictionary, is mapped to standard concepts drawn from vocabularies such as SNOMED CT, RxNorm, and LOINC. The payoff is reproducibility: a cohort definition written once in OHDSI’s open-source tooling executes unchanged against any conformant database. That property is what allows a research network to ask one question of fifty databases and trust that the fifty answers are comparable — the foundation of large-scale observational research.

FHIR: resources and APIs for moving data

FHIR models clinical information as discrete resources — Patient, Observation, Condition, MedicationRequest — exchanged over RESTful APIs in JSON or XML. Its centre of gravity is the live clinical transaction: an app requesting a patient’s current medications, a system pushing a lab result, a portal assembling a record on demand. The SMART on FHIR framework layers standardised authorisation on top, and the FHIR Bulk Data Access specification extends the model from single-patient reads to population-scale export — the mechanism most relevant to research. FHIR R4 remains the dominant deployed version, with R5 and subsequent releases extending the model.

Different centres of gravity

The deep difference is temporal and semantic. FHIR represents data as the source system holds it now, preserving source nuance; profiles constrain it, but semantics still vary between implementations. OMOP normalises aggressively — one vocabulary, one schema, longitudinal by construction — accepting some loss of source fidelity in exchange for cross-database comparability. Exchange standards optimise for faithfulness to the sender; analysis standards optimise for comparability across senders. No amount of engineering makes one standard do the other’s job well.

OMOP vs FHIR: the comparison

The harmonisation pipeline: FHIR in, OMOP out

In mature research architectures the two standards form a pipeline rather than a rivalry. FHIR APIs — increasingly the only sanctioned interface to hospital systems — extract the data; an extract-transform-load process performs data harmonisation into the OMOP CDM, mapping source codes to standard concepts and reshaping transactions into longitudinal records; and researchers work against the OMOP layer with reproducible, shareable analysis code. OHDSI and HL7 have collaborated on this junction, and community-maintained FHIR-to-OMOP mappings continue to mature, because nearly every serious real-world-evidence programme ends up building exactly this pipeline.

Harmonisation is also where the effort genuinely lives. Mapping a hospital’s data to OMOP is not a file-format conversion; it is a semantic exercise — deciding what a local code means, validating mappings with clinicians, and measuring data quality before and after. The OHDSI community’s data-quality tooling exists precisely because a syntactically valid OMOP instance can still be analytically wrong: implausible dates, orphaned concepts, and mapping gaps all pass a schema check and fail a study. Programmes that budget for harmonisation as an ongoing capability, rather than a one-off migration, are the ones whose networks keep producing evidence. Public infrastructure demonstrates the payoff at scale: the European Health Data and Evidence Network (EHDEN) project supported the mapping of well over a hundred European data sources to OMOP, and the All of Us Research Program exposes its curated data to researchers through an OMOP-based model — both cited here as public research infrastructure. For a deeper treatment of the model itself, see this guide to the OMOP common data model.

What about the other standards?

OMOP and FHIR are not the only names in the room, and it helps to place the rest. The Clinical Data Interchange Standards Consortium (CDISC) standards — SDTM and ADaM — govern regulated clinical-trial submissions and remain mandatory in that lane; they are complements, not competitors, to observational standards. openEHR takes a different architectural bet, modelling the clinical record itself through archetypes, and has genuine traction in national EHR procurement — but its research-analysis ecosystem is thinner than OHDSI’s. Legacy research models such as i2b2 persist in academic medical centres, and most eventually gain an OMOP export path. The practical reading: none of these displaces the FHIR-for-exchange, OMOP-for-analysis pairing in observational research; they define the boundaries of the lanes beside it.

Where federation changes the question

The choice becomes sharpest in federated research networks, where participating institutions keep their data behind their own walls and the data never leaves the source. Federation only works if every node speaks the same analytical language — a federated query is meaningless if “type 2 diabetes” resolves differently at each site. That makes a common data model such as OMOP the lingua franca of federated analytics: each custodian harmonises locally, and a federated Trusted Research Environment dispatches identical analysis code to every node, returning only aggregate results. FHIR still earns its place at each node’s ingestion boundary, but the cross-site contract is the common model. This is the pattern behind OHDSI’s global network studies and behind national-scale federated platforms; the distinction between shipping queries and shipping model updates is explored further in federated analytics versus federated learning.

A decision framework

1. Real-time clinical integration or app development? FHIR, without debate — it is the mandated interface and the ecosystem standard.
2. Multi-database observational research, safety studies, or real-world evidence? OMOP — reproducibility across sources is the whole point, and the OHDSI tooling assumes it.
3. Extracting EHR data to build a research resource? FHIR (often bulk export) as transport, OMOP as destination, with harmonisation as the budgeted middle.
4. Building or joining a federated network? Standardise nodes on OMOP for the analytical contract; use FHIR at each node’s local boundary as needed.
5. Regulatory submissions from real-world data? OMOP-based pipelines give you the reproducibility and provenance regulators increasingly ask evidence generators to demonstrate.

Common pitfalls

Treating FHIR as an analysis platform. Pooling raw FHIR resources from multiple institutions and analysing them directly rediscovers, slowly, why common data models exist: semantic variability wrecks comparability.

Treating OMOP mapping as a one-off project. Vocabularies update, source systems change, and mappings decay; harmonisation needs owners, versioning, and data-quality dashboards.

Ignoring provenance. Whichever standard carries the data, analyses must be traceable to source records — regulators and peer reviewers will ask.

Choosing one standard for ideological reasons. The standards communities themselves collaborate; an architecture that refuses one of them usually ends up reimplementing it badly.

What to do next

Sketch your data flows end to end — clinical source, extraction, harmonisation, analysis, output — and label each hop with the standard that serves it best. In almost every health-research architecture the labels converge on the same answer: FHIR at the boundary where data is exchanged, the OMOP CDM at the core where evidence is generated, and disciplined data harmonisation as the connective tissue that makes the whole pipeline trustworthy.

Frequently asked questions

Is OMOP better than FHIR for health research?

For cross-database analysis, yes: the OMOP CDM plus standardised vocabularies makes study code reproducible across sources, which is the core requirement of observational research. FHIR is better at extracting and exchanging the data in the first place. Most research platforms use both.

Can FHIR data be converted to OMOP?

Yes. FHIR-to-OMOP mapping is a well-trodden harmonisation path, supported by collaboration between the OHDSI and HL7 communities and by open tooling. The conversion is semantic work — mapping source codes to standard concepts — not a mechanical format change.

What is the current version of the OMOP CDM?

OMOP CDM v5.4 is the version in widespread production use across the OHDSI network, with later revisions extending the model. The standardised vocabularies are updated on an ongoing basis and are as central to OMOP as the schema itself.

Why do federated research networks prefer a common data model?

Because a federated query must mean the same thing at every node. When each custodian harmonises to the same model and vocabularies, identical analysis code runs everywhere and only aggregate results move — the data never leaves the source.

Does FHIR support population-scale research access?

Yes, through the FHIR Bulk Data Access specification, which exports cohorts rather than single records. It is the standard mechanism for getting research-scale data out of certified EHR systems and into a harmonisation pipeline.

Do regulators mandate either standard?

United States certification rules require FHIR APIs on electronic health record systems, making FHIR effectively mandatory at the clinical boundary. No regulator mandates OMOP, but multi-database evidence programmes and the EHDS-era secondary-use agenda make a common analysis model a practical necessity.